<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171210037809N7</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-12-09</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Effect of  weight training and whey protein  on gene expression Atrial natriuretic peptide(ANP), Brain natriuretic peptide (BNP) and galactin 3</public_title>
      <acronym></acronym>
      <scientific_title>Effect of a weight training period and whey protein  on gene expression Atrial natriuretic peptide(ANP), Brain natriuretic peptide (BNP) and galactin 3 inactive men 60-65 years old</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-12-08</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>129</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52856</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Other, Other design features: This study was designed with emphasis on anabolic, structural, adaptive, and cardiac damage effects.Research sample are older men in the age range of 60-65 years who live in certain conditions. In previous studies  Used of athletes; young bodybuilders, heart patients and rats.Using free weights (high availability, lower cost than using gyms, not being with young people, etc.) and consuming  protein whey may improve and reduce cardiac biomarkers (heart and brain peptides and Galactin 3) .Also use of supplements (protein Whey) with resistance training  may cause synergistic physiological effects, Blinding description: None of the subjects know what substance they will consume.</study_design>
      <phase>N/A</phase>
      <hc_freetext>We have no disease / The effect of his protein is considered with exercise.</hc_freetext>
      <i_freetext>Intervention 1: training group: Exercise is  a 6-week exercise protocol (3 sessions per week) with an intensity of 60 to 70% of a variable maximum repetition will perform by exercise groups. Intervention 2: training  + Whey Protein group: Exercise is a 6-week exercise protocol (3 sessions per week) with an intensity of 60 to 70% of a variable maximum repetition will perform by exercise groups and Individuals will be requested to bring their daily packages containing 35 grams (30 grams of protein or placebo + 5 grams of syrup powder) daily (one hour before and immediately after exercise or in between Morning and evening meal). Intervention 3: Whey Protein:Individuals will be requested to bring their daily packages containing 35 grams (30 grams of protein or placebo + 5 grams of syrup powder) daily (one hour before and immediately after exercise or in between Morning and evening meal). Intervention 4: No training and supplements.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Siavash Shahdusti</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>naghshe- jahan</address>
        <city>Varamin-Pishva</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>33817-74895</zip>
        <telephone>+98 21 3672 5011</telephone>
        <email>info@iauvaramin.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Siavash Shahdusti</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>naghshe-jahan/ IAU</address>
        <city>Varamin- Pishva</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>33817-74895</zip>
        <telephone>021036725011</telephone>
        <email>dastavard96@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Over the past six months, they have not consumed any supplements or medications
It does not exclude any history of common chronic health problems and diseases, such as respiratory, metabolic, cardiovascular, renal and hepatic diseases</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>65 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Over the past six months, they have not consumed any supplements or medications
It does not exclude any history of common chronic health problems and diseases, such as respiratory, metabolic, cardiovascular, renal and hepatic diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>training group: Exercise is  a 6-week exercise protocol (3 sessions per week) with an intensity of 60 to 70% of a variable maximum repetition will perform by exercise groups.</i_keyword>
      <i_keyword>training  + Whey Protein group: Exercise is a 6-week exercise protocol (3 sessions per week) with an intensity of 60 to 70% of a variable maximum repetition will perform by exercise groups and Individuals will be requested to bring their daily packages containing 35 grams (30 grams of protein or placebo + 5 grams of syrup powder) daily (one hour before and immediately after exercise or in between Morning and evening meal)</i_keyword>
      <i_keyword>Whey Protein:Individuals will be requested to bring their daily packages containing 35 grams (30 grams of protein or placebo + 5 grams of syrup powder) daily (one hour before and immediately after exercise or in between Morning and evening meal)</i_keyword>
      <i_keyword>No training and supplements</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Atrial natriuretic peptide(ANP). Timepoint: At the beginning of the study (before the intervention) and after 6 weeks of supplementation and exercise. Method of measurement: Blood collection :changes Atrial natriuretic peptide (ANP): pg /ml.</prim_outcome>
      <prim_outcome>Brain natriuretic peptide(BNP). Timepoint: At the beginning of the study (before the intervention) and after 6 weeks of supplementation and exercise. Method of measurement: Blood collection :changes Atrial natriuretic peptide(BNP) : pg /ml.</prim_outcome>
      <prim_outcome>Galectin3. Timepoint: At the beginning of the study (before the intervention) and after 6 weeks. Method of measurement: Blood collection :changes Galectin 3 : pmo /ml.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-04-21</approval_date>
        <contact_name>Ethics Committee of the Faculty of Medical Sciences of Islamic Azad University, Varamin Prison</contact_name>
        <contact_address>naghshe- jahan/ IAU VARAMIN varamin/ pishva Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
